Elevated circulating GDF15 levels have been consistently associated with adverse outcomes in obesity-related metabolic disorders, heart failure, and atherosclerosis, underscoring their diagnostic and prognostic significance (Adela and Banerjee, 2015). This evidence concerns the gene GDF15 and obesity disorder.